* 中国生物科技公司--歌礼制药1672.HK周三早盘涨幅扩大至5.8%，创3月25日以来新高。
* 该公司此前公告称，地尼法司他治疗中重度寻常性痤疮的III期临床试验达到所有主要、关键次要及次要终点。皮脂分泌过剩是导致痤疮的主要诱因之一，而地尼法司他可直接减少皮脂分泌过剩。
* 歌礼制药今年迄今暴涨177.4%，同期恒生指数.HSI大幅上扬17.9%。
* 恒生香港上市生物科技指数.HSHKBIO盘中一度升4.9%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 张喜良)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.